On the day that the UN World Health Organization (WHO) announced that Ebola deaths in the West African Outbreak have topped 1,900, officials in Canada are working out how to transport up to a thousand doses of an experimental vaccine to the place where it is needed the most.

Ottawa in early August announced it would donate the vaccine to the WHO, but nearly a month later the doses are still sitting in the national laboratory in Winnipeg.

“We are now working with the WHO to address complex regulatory, logistical and ethical issues so that the vaccine can be safely and ethically deployed as rapidly as possible,” said Health Canada spokesman Sean Upton.

“For example, the logistics surrounding the safe delivery of the vaccine are complicated,” Upton added, referring to the necessity of keeping the vaccine properly refrigerated to remain potent in nations just north of the Equator.

Meanwhile, 29-year old William Pooley has been declared free of the Ebola virus and released from Royal Free Hospital in London.  Pooley was airlifted to London on 24 August after contracting the hemorrhagic fever in Sierra Leone. 

He was treated with the experimental drug ZMapp.  Pooley said his symptoms “never progressed to the worst stage of the disease - people I have seen dying horrible deaths”, and he was spared the nausea associated with Ebola.

American missionary worker Nancy Writebol spoke to reporters for the first time since being released from hospital.  She credited her faith, treatment at the special isolation unit at Atlanta’s Emory University, and ZMapp for her recovery.